Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Cyclerion Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CYCN.
You can purchase shares of Cyclerion Therapeutics (NASDAQ:CYCN) through any online brokerage.
Other companies in Cyclerion Therapeutics’s space includes: Alzamend Neuro (NASDAQ:ALZN), Dermata Therapeutics (NASDAQ:DRMA), Can Fite Biofarma (AMEX:CANF), NuCana (NASDAQ:NCNA) and Indaptus Therapeutics (NASDAQ:INDP).
There is no analysis for Cyclerion Therapeutics to provide a consensus price target.
The stock price for Cyclerion Therapeutics (NASDAQ: CYCN) is $2.6501 last updated March 27, 2025 at 5:21 PM EDT.
There are no upcoming dividends for Cyclerion Therapeutics.
Cyclerion Therapeutics’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
There is no upcoming split for Cyclerion Therapeutics.
Cyclerion Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.